By Regulatory Approvals — US FDA Clears Acepodia’s ACE723 IND for Phase I Trial in Liver Cancer BioPharma APAC
Read the original at Regulatory Approvals ↗
Auto-published by the finit.news Events monitor from Regulatory Approvals; summarized by AI and may contain errors — verify against the primary source. September 6, 2026.